The film recounts the story of John Rogers Jr., highlighting the significant advancements in child healthcare in Michigan since his birth over 25 years ago. It contrasts the past, where many children ...

In extreme cases, the swelling can be profound, resulting in a condition known as elephantiasis. This is because the worm ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Fluctuations in hormones can trigger a period to start. Although symptoms can vary from person to person, certain signs may indicate that a period is about to start. These can include bloating ...

RA symptoms typically affect the hands, wrists, and feet. Early and consistent management of arthritis can prevent further joint damage. This article explores the early signs and symptoms of RA ...

What is a heart attack? Centers for Disease Control and Prevention. Stroke signs and symptoms. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients ...

Here are the signs of each. As new COVID-19 variants arise, symptoms may change and can vary depending on vaccination status, according to the CDC. Triple threat of illness: Why is everyone sick ...

Pfizer will focus on Hympavzi, the first U.S.-approved anti-TFPI for hemophilia. Beqvez was FDA-approved in April 2024 but saw low adoption from patients. Get 5 stock picks identified before their ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

Anxiety isn’t listed on any hemophilia fact sheet, but it should be. We learn to be hyperaware of our bodies, always scanning for signs of a problem. That constant state of alertness can be exhausting ...

Several pharma companies are struggling to turn a profit on cell and gene therapies, particularly for rare disorders such as haemophilia. Image credit: Shutterstock/ ShU studio. Pfizer will end the ...

Pfizer will no longer develop and commercialize its hemophilia B gene therapy Beqvez across all of its global markets, according to multiple media reports Thursday. In a statement to Nikkei Asia, the ...